INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 180 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $234,000 | -34.3% | 16,800 | -23.1% | 0.00% | 0.0% |
| Q4 2021 | $356,000 | -46.3% | 21,855 | -51.0% | 0.00% | -50.0% |
| Q3 2021 | $663,000 | -44.8% | 44,623 | -25.8% | 0.00% | -60.0% |
| Q2 2021 | $1,200,000 | +81.3% | 60,100 | +109.4% | 0.01% | +66.7% |
| Q1 2021 | $662,000 | +138.1% | 28,704 | +155.3% | 0.00% | +200.0% |
| Q4 2020 | $278,000 | -77.8% | 11,244 | -43.5% | 0.00% | -88.9% |
| Q1 2020 | $1,252,000 | +78.9% | 19,898 | +252.9% | 0.01% | +80.0% |
| Q4 2019 | $700,000 | -10.6% | 5,639 | -52.2% | 0.01% | -28.6% |
| Q3 2019 | $783,000 | +66.6% | 11,800 | +180.8% | 0.01% | +133.3% |
| Q1 2019 | $470,000 | -2.1% | 4,202 | +10.6% | 0.00% | 0.0% |
| Q3 2018 | $480,000 | – | 3,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |